Patent Assignment
Reel/Frame 059302/0501
Security Interest
Recorded: 2022-03-18
Pages: 23
Assignor
UROGEN PHARMA LTD.
Executed: 2022-03-16
Assignee
BIOPHARMA CREDIT PLC
C/O BEAUFORT HOUSE, 51 NEW NORTH ROAD, EXETER EX4 4EP, UNITED KINGDOM
Covered Properties
(42)
Biocompatible Drug Delivery Apparatus and Methods
Phospholipid Drug Analogs
Pharmaceutical Compositions Comprising Imidazoquinolin(Amines) and Derivatives Thereof Suitable for Local Administration
Material and Method for Treating Internal Cavities
Methods for Treatment of Bladder Cancer
Biocompatible Drug Delivery Apparatus and Methods
Phospholipid Drug Analogs
Phospholipid Drug Analogs
Pharmaceutical Compositions Comprising Imidazoquinolin(Amines) and Derivatives Thereof Suitable for Local Administration
Phospholipid Drug Analogs
Material and Method for Treating Internal Cavities
Slow Release Formulations of Cell Cycle Regulators and Anti-Cancer Agents for Local Treatment of Solid Cancer
Patent:
9,801,854 →
Application:
14/600,354 →
Methods for Treatment of Bladder Cancer
Material and Method for Treating Internal Cavities
Phospholipid Drug Analogs
Anti-Ctla-4 Antibodies and Methods of Use Thereof
A Connectable Catheter
Material and Method for Treating Internal Cavities
Anti-Ctla-4 Antibodies and Methods of Use Thereof
Immunomodulating Treatments of Body Cavities
Antibodies and Methods of Use Thereof
Material and Method for Treating Internal Cavities
Application:
16/518,511 →
Publication:
US 2020/0114008
Anti-Ctla-4 Antibodies and Methods of Use Thereof
Application:
16/572,216 →
Pharmaceutical Compositions Comprising Imiquimod for Use in the Treatment of Carcinoma in Situ of the Bladder
Application:
16/593,297 →
Publication:
US 2020/0276183
Anti-Ctla-4 Antibodies and Methods of Use Thereof
Immunomodulating Treatments of Body Cavities
Application:
17/006,926 →
Publication:
US 2020/0397695
Material and Method for Treating Cancer
Material and Method for Treating Internal Cavities
Application:
17/566,882 →
Publication:
US 2022/0118096
Anti-Ctla-4 Antibodies and Methods of Use Thereof
Anti-CTLA4 Antibodies and Methods of Use Thereof
Application:
62/168,391 →
Anti-CTLA4 Antibodies and Methods of Use Thereof
Application:
62/182,363 →
Anti-Ctla-4 Antibodies and Methods of Use Thereof
Application:
62/190,653 →
Anti-Ctla-4 Antibodies and Methods of Use Thereof
Application:
62/257,202 →
Anti-Ctla-4 Antibodies and Methods of Use Thereof
Application:
62/280,263 →
Anti-Ctla-4 Antibodies and Methods of Use Thereof
Application:
62/292,500 →
Anti-Ctla-4 Antibodies and Methods of Use Thereof
Application:
62/294,558 →
Anti-Ctla-4 Antibodies and Methods of Use Thereof
Application:
62/323,226 →
Antibodies and Methods of Use Thereof
Application:
62/431,279 →
Antibodies and Methods of Use Thereof
Application:
62/570,451 →
Antibodies and Methods of Use Thereof
Application:
62/582,814 →
Antibodies and Methods of Use Thereof
Application:
62/586,605 →
Thermosensitive Bio-Adhesive Hydrogel for Removal of Ureteral and Renal Stones
Application:
63/165,744 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 16, 2004
From: HOLZER, ASHER; DANIEL, DORIT; HIRSZOWICZ, ERAN
To: THERACOAT LTD.
Reel/Frame 015817/0081 →
Assignment of Assignor's Interest
Sep 14, 2011
From: LEONI, LORENZO; MAJ, ROBERTO; PATTARINO, FRANCO; VECCHIO, CARLO
To: TELORMEDIX SA
Reel/Frame 026906/0392 →
Assignment of Assignor's Interest
Sep 19, 2011
From: MAJ, ROBERTO; PATTARINO, FRANCO; MURA, EMANUELA; BARBERIS, ALCIDE
To: TELORMEDIX SA
Reel/Frame 026930/0047 →
Assignment of Assignor's Interest
Nov 5, 2012
From: HOLZER, ASHER; DANIEL, DORIT; MULLERAD, MICHAEL; DE LA ZERDA, JAIME
To: THERACOAT LTD.
Reel/Frame 029238/0909 →
Assignment of Assignor's Interest
Jun 13, 2013
From: HOLZER, ASHER; DANIEL, DORIT; HIRSZOWICZ, ERAN
To: THERACOAT LTD.
Reel/Frame 030605/0477 →
Assignment of Assignor's Interest
Jun 20, 2013
From: MAJ, ROBERTO; PATTARINO, FRANCO; MURA, EMANUELA; BARBERIS, ALCIDE
To: TELORMEDIX SA
Reel/Frame 030655/0891 →
Assignment of Assignor's Interest
Nov 3, 2013
From: LEONI, LORENZO; MAJ, ROBERTO; PATTARINO, FRANCO; VECCHIO, CARLO
To: TELORMEDIX SA
Reel/Frame 031533/0541 →
Assignment of Assignor's Interest
Nov 15, 2013
From: MAJ, ROBERTO; PATTARINO, FRANCO; MURA, EMANUELA; BARBERIS, ALCIDE
To: TELORMEDIX SA
Reel/Frame 031615/0637 →
Assignment of Assignor's Interest
Nov 20, 2013
From: MAJ, ROBERTO; PATTARINO, FRANCO; MURA, EMANUELA; BARBERIS, ALCIDE
To: TELORMEDIX SA
Reel/Frame 031639/0166 →
Assignment of Assignor's Interest
Jan 9, 2014
From: KONORTY, MARINA; HAKIM, GIL
To: THERACOAT LTD
Reel/Frame 031947/0586 →
Assignment of Assignor's Interest
Oct 27, 2015
From: MAJ, ROBERT; PATTARINO, FRANCO; MURA, EMANUELA; BARBERIS, ALCIDE
To: TELORMEDIX SA
Reel/Frame 036895/0721 →
Change of Name
Nov 13, 2015
From: THERACOAT LTD
To: UROGEN PHARMA LTD
Reel/Frame 037111/0567 →
Asset Purchase Agreement
Nov 13, 2015
From: TELORMEDIX SA
To: THERACOAT LTD.
Reel/Frame 037109/0769 →
Change of Name
Nov 24, 2015
From: THERACOAT LTD.
To: UROGEN PHARMA LTD.
Reel/Frame 037135/0053 →
Change of Name
Jan 19, 2016
From: THERACOAT LTD.
To: UROGEN PHARMA LTD.
Reel/Frame 037553/0678 →
Assignment of Assignor's Interest
Feb 4, 2016
From: TELORMEDIX, SA
To: UROGEN PHARMA LTD.
Reel/Frame 037668/0353 →
Assignment of Assignor's Interest
Jul 12, 2016
From: 4-ANTIBODY AG
To: AGENUS INC.
Reel/Frame 039136/0571 →
Assignment of Assignor's Interest
Jul 12, 2016
From: RITTER, GERD
To: LUDWIG INSTITUTE FOR CANCER RESEARCH LTD
Reel/Frame 039136/0576 →
Assignment of Assignor's Interest
Jul 12, 2016
From: VAN DIJK, MARC; MUNDT, CORNELIA ANNE
To: 4-ANTIBODY AG
Reel/Frame 039136/0563 →
Assignment of Assignor's Interest
Jul 12, 2016
From: WILSON, NICHOLAS STUART; SAVITSKY, DAVID ADAM; FINDEIS, MARK ARTHUR
To: AGENUS INC.
Reel/Frame 039136/0516 →
Assignment of Assignor's Interest
Jul 18, 2016
From: WOLCHOK, JEDD DAVID; MERGHOUB, TAHA; SCHAER, DAVID
To: MEMORIAL SLOAN KETTERING CANCER CENTER
Reel/Frame 039174/0467 →
Assignment of Assignor's Interest
Aug 16, 2017
From: HAKIM, GIL; DOLLBERG, YOSH; MALCHI, NADAV
To: UROGEN PHARMA LTD.
Reel/Frame 043304/0556 →
Change of Name
Jan 8, 2018
From: THERACOAT LTD.
To: UROGEN PHARMA LTD.
Reel/Frame 045016/0287 →
Assignment of Assignor's Interest
Jan 8, 2018
From: HOLZER, ASHER; DANIEL, DORIT; MULLERAD, MICHAEL; DE LA ZERDA, JAIME
To: THERACOAT LTD.
Reel/Frame 044556/0637 →
Change of Name
Mar 15, 2021
From: THERACOAT LTD.
To: UROGEN PHARMA LTD.
Reel/Frame 055588/0095 →